Skip to content
Parakho

Godavari Biorefineries Ltd

NSE GODAVARIBBSE 544279godavaribiorefineries.com

Q1 FY27, unaudited

Revenue
₹557.88 Cr
Profit after tax
₹-19.32 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations557.88—1,987.94
Other income2.05—12.21
Total income559.93—2,000.15
Employee benefit expense33.01—135.22
Finance costs13.93—49.13
Depreciation & amortisation14.49—54.49
Total expenses585.77—1,964.45
Profit before tax-25.85—4.57
Tax expense-6.53—1.04
Profit after tax-19.32—3.53
Total comprehensive income-18.65—4.45
Earnings per share
Earnings per share, basic₹-3.78₹0.69
Earnings per share, diluted₹-3.78₹0.69

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q1 FY27

Godavari Biorefineries reported Q1 FY27 total income growth of 4.9% year-on-year, with the bio-based chemicals business posting 19.4% revenue growth and 53% EBITDA growth while the integrated sugar, cogeneration and ethanol segment reported a widened EBITDA loss. The company commissioned a 200 kilolitres per day grain-based distillery at Sameerwadi, taking total distillery capacity to 800 kilolitres per day, and is evaluating an additional 160 kilolitres per day fungible capacity. Management also reported progress on drug discovery, having filed a CDSCO application for preliminary efficacy trials of its triple-negative breast cancer molecule and secured patents for an anticancer molecule and branched alcohols process.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 55 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Fast Moving Consumer Goods › Diversified FMCG

Classification as published by BSE.

Companies also in Diversified FMCG, in alphabetical order

All 5 companies in Diversified FMCG

Page generated from filings held to 08 Oct 2026.